Exelixis
EXEL
#1325
Rank
C$23.93 B
Marketcap
C$98.09
Share price
1.25%
Change (1 day)
68.80%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

EPS for Exelixis (EXEL)

EPS in 2023 (TTM): C$0.38

According to Exelixis's latest financial reports the company's current EPS (TTM) is C$4.88. In 2022 the company made an earnings per share (EPS) of C$0.80 a decrease over its 2021 EPS that were of C$1.04.

EPS history for Exelixis from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$0.38-53.27%
2022C$0.80-22.97%
2021C$1.04100%
2020C$0.52-65.09%
2019C$1.49-53.91%
2018C$3.24333.96%
2017C$0.75-260.61%
2016C-$0.47-58.75%
2015C-$1.13-42.45%
2014C-$1.965.3%
2013C-$1.8643.48%
2012C-$1.30-264.29%
2011C$0.79-165.88%
2010C-$1.20-32.54%
2009C-$1.78-17.65%
2008C-$2.1675.86%
2007C-$1.23-25.64%
2006C-$1.658.33%
2005C-$1.52-42.86%
2004C-$2.6630.34%
2003C-$2.04-5.23%
2002C-$2.16-0.65%
2001C-$2.17-51.88%
2000C-$4.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.43 93.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.07-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$22.87 368.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.68-45.00%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$1.40-71.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.37 30.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.06-16.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
C-$20.05-510.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.18-124.28%๐Ÿ‡บ๐Ÿ‡ธ USA